Clinical Trials Logo

Pain clinical trials

View clinical trials related to Pain.

Filter by:

NCT ID: NCT01864213 Completed - Pain Clinical Trials

Efficacy of Ametop Cream in Reducing Pain of Local Anesthetic Infiltration

Ametop
Start date: May 2013
Phase: Phase 1
Study type: Interventional

Ametop is a numbing cream used to ease the pain of having blood drawn or an IV inserted. It is safe and virtually none enters the blood stream. It's effectiveness at reducing the pain of the freezing injection prior to epidural/ spinal anesthesia in pregnant women has not been studied.

NCT ID: NCT01862848 Completed - Pain Clinical Trials

Topical Compounded Pain Creams And Pain Perception (TOPCAPP)

TOPCAPP
Start date: November 2012
Phase: N/A
Study type: Observational [Patient Registry]

To evaluate the change in patient pain perception with the use of a topical compounded pain cream regimen.

NCT ID: NCT01860950 Completed - Pain Clinical Trials

Effects of Transcranial Direct Current Stimulation on Pain Perception

tDCS-CBT
Start date: October 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether a new medical technology can temporarily alter pain perception. The new technology is called Transcranial direct current stimulation (tDCS).

NCT ID: NCT01855113 Completed - PAIN Clinical Trials

COMPARISON OF THE PERCEPTION OF PAIN BETWEEN ORTHODONTIC TREATMENT WITH Invisalign ® AND TREATMENT WITH BRACKETS

Start date: June 2013
Phase:
Study type: Observational

This study aims to compare the pain experienced by patients undergoing orthodontic treatment with Invisalign ® corrective aligners with that of patients undergoing orthodontic treatment with conventional braces. Because the aligners are removable, nearly invisible and don't involve metal that can irritate teeth and gums, we are expecting less pain in the Invisalign Treatment and less affectation of the quality of life.

NCT ID: NCT01852955 Completed - Pain Clinical Trials

Perioperative Systemic Acetaminophen to Improve Postoperative Quality of Recovery After Ambulatory Breast Surgery

Start date: November 2013
Phase: N/A
Study type: Interventional

Recent evidence demonstrates that perioperative pain continues to be poorly managed among ambulatory surgical patients. More importantly, few interventions that minimize postoperative pain have also shown to improve patient overall quality of post-surgical recovery. Ketorolac has been used to minimize perioperative pain despite the lack of evidence for its use when administered as a single dose preventive strategy.Ketorolac has also been associated with a higher incidence of perioperative hematomas and the need for surgical re-exploration after breast surgery. Systemic acetaminophen has become recently available in The United States. In contrast to ketorolac, systemic acetaminophen has not been reported to have adverse side effects on patients undergoing breast surgery. Although evidence suggests that a single dose perioperative acetaminophen reduces postoperative pain, it remains unknown if a single dose intravenous acetaminophen improves postoperative quality of recovery after ambulatory surgery. The main objective of the current investigation is to evaluate the effect of a single dose systemic acetaminophen on postoperative quality of recovery after ambulatory breast surgery. We also seek to determine if systemic acetaminophen would decrease postoperative pain and the time to hospital discharge in the same population. Significance: The current project evaluates a potential intervention to improve perioperative pain and recovery after ambulatory breast surgery. Postoperative pain in the ambulatory surgical patients has been shown consistently to be poorly managed.

NCT ID: NCT01848119 Completed - Pain Clinical Trials

Does a Perioperative Course of Gabapentin Improve Analgesia After Cesarean Delivery?

Start date: May 2013
Phase: N/A
Study type: Interventional

Gabapentin has been very effective at treating pain after knee and hip operations, hysterectomies, and many other types of operations. A previous study at the investigators' hospital found that a single pre-operative dose of 600mg gabapentin produced a significant reduction in pain after cesarean section. However, 19% of patients complained of sedation. A subsequent study at the same institution looked to see if lowering the dose to 300mg would decrease pain scores whilst reducing the sedative side-effect seen in the first trial. The results were inconclusive but it provided valuable information to guide the design of this study. The purpose of this study is to see whether a preoperative dose of gabapentin, followed by a 48 hour low-dose course will produce improvement in pain scores. This study will compare the efficacy of a peri-operative course of gabapentin (600mg one hour before the operation and 200mg every 8 hours for 2 days post-operatively) and a similar course of placebo in women undergoing Cesarean section. The investigators' hypothesis is that a course of gabapentin will result in decreased pain scores and increased satisfaction.

NCT ID: NCT01847976 Completed - Pain Clinical Trials

Combining Doxycycline With Bone-Targeted Therapy in Patients With Metastatic Breast Cancer

OTT12-05
Start date: August 2013
Phase: Phase 2
Study type: Interventional

The purpose of this study is to see if women with bone metastases from breast cancer will benefit from the addition of doxycycline to their standard bone-targeted therapy. Participants will be asked to take 100 mg of Doxycycline orally twice a day for 12 weeks. Blood and tissue collection will further define the mechanism of the benefits if there are any.

NCT ID: NCT01846117 Completed - Pain Clinical Trials

Once-Daily Oral Dose of BeneFlax to Healthy Older Adults

MOD
Start date: April 2013
Phase: Phase 1/Phase 2
Study type: Interventional

The investigators are investigating whether the flax lignan, secoisolariciresinol diglucoside, decreases oxidative stress and inflammation. The flax seed lignan is believed to be broken down in the body to produce the health benefits of flax. Flax lignan is separated from the whole flax seed as this compound is believed to have health effects. Decreasing oxidative stress and inflammation should improve a number of the problems associated with aging. This intervention consists of 600 milligrams of the flax lignan SDG daily or an equivalent amount of whey protein. The investigators are comparing lignan to a placebo (whey powder) to examine whether a dietary intervention (i.e. flax seed containing lignan) might decrease oxidative stress and inflammation.

NCT ID: NCT01843907 Completed - Depression Clinical Trials

Patient Participation in Prevention of Loss of Functions

Start date: January 2013
Phase: N/A
Study type: Interventional

Randomized Clinical Trial (RCT) To investigate and compare the effect of two preventive interventions on readmission rates, loss of functions, quality of life and cost-benefit.

NCT ID: NCT01843153 Completed - Pain Clinical Trials

Continuous Versus Intermittent Sciatic Block for Total Knee Arthroplasty

Start date: April 2013
Phase: Phase 4
Study type: Interventional

The role of a sciatic block in addition to a femoral block remains controversial. The study addresses this topic by comparing a continuous block versus an injection on demand.